|
RITUXAN® (rituximab) Coverage / Reimbursement
RITUXAN® (rituximab) DIN 02241927
Roche Patient Assistance Program 1-888-748-8926
The Roche Patient Assistance Program is a service for patients who require reimbursement and infusion support for Roche oncology, hematology and rheumatology therapies that are approved by Health Canada. Services include call centre support; financial assistance; reimbursement navigation; infusion coordination (if required); and coordination of distribution and pharmacy services. For more information about the program, please call toll-free 1-888-748-8926.
RITUXAN is indicated for use in non-hodgkin’s lymphoma, chronic lymphocytic leukemia and in rheumatoid arthritis.
Reimbursement Information for RITUXAN:
 Non-Hodgkin’s Lymphoma and
Chronic Lymphocytic Leukemia
 Rheumatoid Arthritis
For All Conditions - Call the Roche Patient Assistance Program 1-888-748-8926
® Registered Trade-Mark of IDEC Pharmaceuticals Corporation, used under license by Hoffmann-La Roche Limited
|
